FI862644A - Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar. - Google Patents

Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar. Download PDF

Info

Publication number
FI862644A
FI862644A FI862644A FI862644A FI862644A FI 862644 A FI862644 A FI 862644A FI 862644 A FI862644 A FI 862644A FI 862644 A FI862644 A FI 862644A FI 862644 A FI862644 A FI 862644A
Authority
FI
Finland
Prior art keywords
tiazoler
foereningar
deras framstaellning
framstaellning och
dessa innehaollande
Prior art date
Application number
FI862644A
Other languages
English (en)
Finnish (fi)
Other versions
FI862644A0 (fi
Inventor
Dieter Sorg
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI862644A0 publication Critical patent/FI862644A0/fi
Publication of FI862644A publication Critical patent/FI862644A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI862644A 1985-06-22 1986-06-19 Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar. FI862644A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3522354 1985-06-22
DE3522351 1985-06-22
DE3522353 1985-06-22
DE3605868 1986-02-24

Publications (2)

Publication Number Publication Date
FI862644A0 FI862644A0 (fi) 1986-06-19
FI862644A true FI862644A (fi) 1986-12-23

Family

ID=27433378

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862644A FI862644A (fi) 1985-06-22 1986-06-19 Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar.

Country Status (17)

Country Link
US (2) US4737500A (es)
AU (1) AU5894086A (es)
BE (1) BE904945A (es)
CH (1) CH668426A5 (es)
DK (1) DK292986A (es)
ES (2) ES8802154A1 (es)
FI (1) FI862644A (es)
FR (1) FR2587342A1 (es)
GB (1) GB2177395B (es)
GR (1) GR861601B (es)
HU (1) HUT43600A (es)
IL (1) IL79178A0 (es)
IT (1) IT1203806B (es)
LU (1) LU86487A1 (es)
NL (1) NL8601494A (es)
PH (1) PH23389A (es)
SE (1) SE8602723L (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
HUT43600A (en) * 1985-06-22 1987-11-30 Sandoz Ag Process for production of new thiazole derivatives and medical compound containing those
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
US4804751A (en) * 1987-06-30 1989-02-14 American Home Products Corporation Polycyclic hydrocarbon succinimides with psychotropic activity
EP0307141B1 (en) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazoles and thiazoles for the treatment of senile dementia
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
US4935424A (en) * 1988-05-27 1990-06-19 Warner-Lambert Company 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US5077295A (en) * 1988-09-16 1991-12-31 Pfizer Inc. Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
SK282231B6 (sk) 1993-11-19 2001-12-03 Janssen Pharmaceutica N. V. Farmaceutický prostriedok na liečenie psychotických porúch
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
DE19746612A1 (de) 1997-10-22 1999-04-29 Basf Ag 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
BRPI0510074A (pt) * 2004-04-22 2007-10-16 Boehringer Ingelheim Int composições farmacêuticas para o tratamento de distúrbios sexuais ii
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
WO2006024471A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
CA2599721A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2006096434A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2006119884A2 (en) * 2005-05-06 2006-11-16 Boehringer Ingelheim International Gmbh Method for the treatment of drug abuse with flibanserin
JP2008540673A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤誘発性性機能不全の治療方法
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
JP2009536176A (ja) * 2006-05-09 2009-10-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 閉経後の性的欲求障害の治療のためのフリバンセリンの使用
DE602007004615D1 (de) 2006-06-30 2010-03-18 Boehringer Ingelheim Pharma Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
WO2008006838A1 (en) * 2006-07-14 2008-01-17 Boehringer Ingelheim International Gmbh Use of flibanserin for the treatment of sexual disorders in females
AR062320A1 (es) 2006-08-14 2008-10-29 Boehringer Ingelheim Int Formulaciones de flibanserina y metodo para fabricarlas
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
EA200900270A1 (ru) 2006-08-25 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Системы регулируемого высвобождения и способ их приготовления
PT2159226T (pt) * 2007-03-29 2016-12-16 Joint-Stock Company Obninsk Chemical Pharmaceutical Company Agente anti-histamínico e antialérgico e um método para a produção do mesmo
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297170A (es) * 1963-04-04 1900-01-01
DE1595923A1 (de) * 1965-02-20 1969-11-27 Merck Ag E 1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
JPS5246935B1 (es) * 1971-04-06 1977-11-29
BE787059A (fr) * 1971-08-03 1973-02-01 Wander Ag Dr A Nouveaux derives du thiazole, leur preparation et leur application comme medicaments
CH583232A5 (es) * 1973-02-02 1976-12-31 Wander Ag Dr A
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
HUT43600A (en) * 1985-06-22 1987-11-30 Sandoz Ag Process for production of new thiazole derivatives and medical compound containing those

Also Published As

Publication number Publication date
FR2587342A1 (fr) 1987-03-20
US4737500A (en) 1988-04-12
ES8802045A1 (es) 1988-03-16
SE8602723L (sv) 1986-12-23
DK292986A (da) 1986-12-23
NL8601494A (nl) 1987-01-16
SE8602723D0 (sv) 1986-06-18
IL79178A0 (en) 1986-09-30
FI862644A0 (fi) 1986-06-19
US4892879A (en) 1990-01-09
GB2177395A (en) 1987-01-21
GB2177395B (en) 1989-04-26
GB8614974D0 (en) 1986-07-23
IT8648157A0 (it) 1986-06-20
HUT43600A (en) 1987-11-30
PH23389A (en) 1989-07-26
ES8802154A1 (es) 1988-04-01
IT1203806B (it) 1989-02-23
ES556363A0 (es) 1988-04-01
CH668426A5 (de) 1988-12-30
GR861601B (en) 1986-10-20
LU86487A1 (fr) 1987-01-13
AU5894086A (en) 1986-12-24
DK292986D0 (da) 1986-06-20
BE904945A (fr) 1986-12-18
ES557723A0 (es) 1988-03-16

Similar Documents

Publication Publication Date Title
FI862644A0 (fi) Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar.
FI860232A0 (fi) Tiazolidindionderivat, deras framstaellning och anvaendning.
FI860832A (fi) Tiazolidinderivat, deras framstaellning och anvaendning.
FI870012A0 (fi) Medelst kopplingsreaktion erhaollna fosforhaltiga amider, deras prekursorer och dessa innehaollande smoerjmedelkompositioner.
FI860559A0 (fi) 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI862029A (fi) Askorbinsyraderivat, deras framstaellning och anvaendning.
FI863661A (fi) Benzimidazolderivat, deras framstaellning och terapeutiska anvaendning.
FI865264A (fi) Foerfarande foer anvaendning av en spektralskiftskaernreaktor och en kaernreaktor, i vilken anvaends vatten undantraengande knippen.
FI862374A (fi) Foerfarande och anordning foer rundning av plaot, saerskilt foer doskroppar.
FI870734A (fi) Magnetiskt oevervakningssystem foer foeremaol, foerfarande och kodad markoer.
FI862691A (fi) 2-oxy-4h-3,1-benzoxazin-4-on-derivat och deras foereningar.
FI863358A0 (fi) Aminosyra-derivat, foerfarande foer deras framstaellning och anvaendning.
FI863480A0 (fi) Azolyl-cyklopropyl-etanolderivat, foerfarande foer deras framstaellning och deras anvaendning.
FI862478A0 (fi) Vattenbaserade, filmbildande oeverdragskompositioner och deras anvaendning.
FI860870A0 (fi) Antibakteriska foereningar, deras framstaellning och anvaendning.
FI853787A0 (fi) Elektronisk fjaerrstyrnings- och fjaerrmaetningssystem, speciellt foer foerutsaegning och styrning av foeroreningsaemnen.
FI871428A0 (fi) Framstaellning av allylamin och, utgaoende fraon denna, kvaternaera diallylammoniumfoereningar.
FI855131A (fi) 8-acylaminoergoliner, deras framstaellning och farmaceutiska sammansaettningar innehaollande desamma.
FI864566A0 (fi) Nitroantracykliner, foerfarande foer deras framstaellning och deras anvaendning.
FI862851A (fi) Morfoliniokarboxylsyraester- och morfolinioalkylfenyletersalter, deras framstaellningsfoerfarande och deras anvaendning saosom fungicider.
FI850803A0 (fi) Aminodiarylsulfoxiderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska och pesticida foereningar.
FI865240A (fi) Reaktionsfaergaemnen, deras framstaellning och anvaendning.
FI861115A (fi) Imidazo-isokinoliner och imidazo-tienopyridinfoereningar, laekemedel innehaollande dessa foereningar och foerfarande foer deras framstaellning.
FI863794A (fi) Alkenylazoler, foerfaranden foer deras framstaellning och deras anvaendning.
FI861884A0 (fi) Foerfaringssaett foer framstaellning av en gjutmassa, innehaollande vattenglas och eventuellt kvarts.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG